LexisNexis Risk Solutions Identity Proofing for MyChart successfully integrates with Epic to help hospitals strengthen patient portal security. Sep 15, 2026, 09:30 ET Identity Proofing for MyChart is now available in the Epic Toolbox Program as part of the Identity Verification for MyChart Category, offering Epic customers modular identity verification and authentication solutions to support secure digital access ATLANTA, Sept. 15, 2026 /PRNewswire/ - LexisNexis(R) Risk Solutions, a leading provider of data and analytics, announced today that Identity Proofing for MyChart from LexisNexis(R) Risk Solutions is now available in the Epic Toolbox Program as part of the Identity Verification for MyChart Category. The toolbox designation validates that the solution aligns with the Epic integration and functionality best practices. "Being in the Epic Toolbox Program validates that our solution seamlessly aligns with Epic technical blueprints, providing healthcare IT teams with a predictable, repeatable deployment process," said Brad Bauer, SVP and general manager, healthcare, LexisNexis Risk Solutions. "By removing implementation complexity, we enable health systems to quickly protect patient accounts with robust identity proofing that preserves intuitive user workflows." The integration gives U.S. hospitals and health systems using Epic electronic health record systems convenient access to a modular suite of identity verification and risk decisioning tools designed to help protect Epic MyChart accounts and secure patient data while reducing unnecessary friction for legitimate users. Epic customers can select and combine capabilities based on their desired patient experience, operational priorities and level of assurance associated with risk tolerance. With integration available through the Epic Connection Hub, no custom development is required. The launch comes as malicious bot attacks jumped 59% in 2025[1], emphasizing the need for healthcare organizations to secure digital access across patient portals, digital front doors and workforce systems without slowing down care. As patient portals increasingly support high-value interactions such as account creation, login, account recovery, medical record access, messaging, scheduling and payments, hospitals need identity strategies that go beyond passwords or single-point verification. Identity Proofing for MyChart provides access to solutions that use AI and machine learning to analyze patterns across billions of identity events beyond healthcare interactions, giving organizations broader intelligence to apply layered identity proofing within existing workflows. "The stakes for patient portal security have never been higher," said Bauer. "Hospitals can no longer rely on static identity checks when patient portals are becoming central to how people access care, manage records and make payments. Identity Proofing for MyChart gives healthcare organizations a stronger, more adaptive way to verify identity and recognize trusted users." Identity Proofing for MyChart helps organizations assess risk across the healthcare identity access lifecycle and apply the appropriate level of assurance for each interaction. The solution suite offers a range of verification capabilities including digital identity, email, phone association and biometrics intelligence that leverage AI and machine learning to keep up with the latest threats. The suite can support NIST IAL2-level assurance and help organizations move beyond point-in-time identity checks toward risk-based decisioning. "These capabilities help health systems strengthen trust in digital access while preserving the usability patients and workforces expect," said Bauer. "The configurability of the suite of solutions allows healthcare organizations to keep routine interactions relatively simple while managing higher-risk interactions with stronger verification to help defend against emerging threats like synthetic identity fraud, forged documents and deepfake-enabled impersonations." About LexisNexis Risk Solutions LexisNexis(R) Risk Solutions provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency. Headquartered in metro Atlanta, Georgia, the company has offices throughout the world, serves customers in more than 190 countries and territories and is part of RELX. For more information, please visit LexisNexis Risk Solutions. The Healthcare business of LexisNexis Risk Solutions empowers healthcare providers, health plans, pharmacies and life sciences organizations with advanced analytics and technology that can help with identity verification and authentication, provider data management and market data insights. For more information, please visit https://risk.lexisnexis.com/healthcare. Media Contact: Syed Shabbir Director, Communications Insurance and Healthcare LexisNexis Risk Solutions 816-572-7709 [email protected] Epic and MyChart are registered trademarks of Epic Systems Corporation. SOURCE LexisNexis Risk Solutions

Cylerity adds Michael Saito to lead operations and compliance. MADISON, Wis. - September 11, 2026 - Cylerity has hired Michael Saito, formerly of Epic, to lead operations and regulatory compliance as the healthcare fintech company expands its platform across healthcare providers, health systems and financial institutions. Why it matters: Healthcare organizations routinely deliver care and incur costs weeks or months before reimbursement arrives. Cylerity is building infrastructure to make those future healthcare cash flows more usable as a source of working capital. The company combines claims, reimbursement, operational and banking data to help healthcare organizations access liquidity while they wait for payment from Medicare, Medicaid and commercial insurers. As Cylerity expands, the challenge is increasingly operational as well as technical: healthcare data, reimbursement rules, banking controls, provider workflows and regulatory requirements all have to work together. Saito will lead that layer. "Healthcare finance is an orchestration problem," said Ryan Wheeler, founder and CEO of Cylerity. "Clinical systems, claims, payors, banks and regulatory requirements all have to work together. Michael understands how complex healthcare organizations actually operate, and that becomes increasingly important as we scale." At Epic, Saito operationalized nationwide health data exchange frameworks, applying his deep understanding of the complex regulatory and operating environment of healthcare to lead the effort that gave large hospitals and clinics across the country a path to participate. That work now facilitates the exchange of hundreds of millions of patient records for treatment every year. At Cylerity, he will apply that same rigor to the company's work at the intersection of healthcare and finance, beginning with scaling its operational governance and compliance program, to reinforce Cylerity's standing as a trusted partner to the healthcare and financial institutions it serves. The bigger picture: Healthcare has spent decades digitizing clinical and reimbursement workflows, but the financing of those workflows remains comparatively static. Cylerity's thesis is that healthcare reimbursement data can support a more dynamic financial infrastructure allowing capital availability to adjust more closely to the underlying value and timing of healthcare cash flows. "Epic helped build much of the digital infrastructure through which healthcare operates," Wheeler said. "We're building infrastructure that connects those healthcare workflows to the financial system. Michael will help us make that connection operationally durable and scalable." What Cylerity is watching: Cylerity is moving beyond simply accelerating individual claims toward a broader financial infrastructure layer connecting healthcare organizations and capital markets. That raises the stakes around regulatory architecture, data governance and operational controls, particularly as the company works with larger health systems, more sophisticated banking partners and increasingly complex reimbursement structures. The key question is whether healthcare claims and reimbursement data can ultimately support a more flexible, transparent and scalable form of healthcare working-capital finance. Cylerity is betting that it can. About Cylerity. Cylerity, a Madison, Wisconsin-based financial technology company, transforms how healthcare providers access working capital. The company's intelligent financing platform advances funds against insured medical receivables - accelerating cash flow and reducing administrative friction across the healthcare revenue cycle. By combining real-time data analytics, automated underwriting, and secure integrations with third-party payors, Cylerity delivers speed, transparency, and control to providers seeking to grow without compromise. A graduate of the Creative Destruction Lab program, Cylerity is redefining liquidity for the healthcare economy through the power of data-driven finance.

ChatGPT Health is now inside Epic: what devs must know. 8 hours ago 0 OpenAI connected ChatGPT Health to Epic Systems on September 1, embedding AI directly inside the EHR platform that runs clinical operations at roughly 40% of US hospitals and holds records on 325 million patients. This is not a health app launch. It is a platform move - OpenAI inserted itself as the ambient AI layer between clinicians and their patient data, without requiring doctors to switch tools. What actually shipped. The integration operates in two modes. In the first, clinicians pull authorized patient context from Epic - appointment notes, lab results, medications, specialist documentation - into a ChatGPT conversation. In the second, ChatGPT is embedded directly inside the Epic EHR interface, eliminating context-switching entirely. The connection is read-only in both modes. ChatGPT cannot write to the chart, place orders, or alter clinical documentation. Alongside the Epic connector, OpenAI launched a Healthcare Public Data plugin tying ChatGPT to nine official datasets simultaneously: PubMed, ClinicalTrials.gov, CMS Coverage, DailyMed, openFDA, RxNorm, Medicare Care Compare, and two additional government sources. A physician can cross-reference drug interactions against DailyMed and check relevant clinical trials without ever leaving the patient chart. The access tax. None of this is available to organizations that have not done the compliance work. Three requirements apply before any Protected Health Information can touch ChatGPT. First, a signed Business Associate Agreement with OpenAI - without one, HIPAA prohibits using patient data in the system. Second, a ChatGPT Work or Enterprise subscription - the free tier does not qualify. Third, organizational approval from the hospital itself: Epic controls which applications can connect via its FHIR APIs, and health system administrators must explicitly authorize the connection. OpenAI validated safety with physicians across 4,363 ratings spanning 27 clinical use cases: 99.1% rated safe, 93% or higher rated accurate. That sounds reassuring until you run the math - roughly 39 of those evaluations came back problematic. In software, that is noise. In clinical medicine, that is someone's medication contraindication getting missed. Who gets hurt. Every startup that built its product around AI-assisted patient record retrieval is now competing with a ChatGPT bundle. Hospital CIOs have a new default answer when smaller vendors pitch - "we'll wait and see what Epic plus OpenAI does next." That is not a rejection; it is indefinite postponement, which is functionally the same for a company burning runway. The $1.6 billion invested in specialized ambient documentation tools - Abridge, Ambience, Suki, Heidi - is safer. Read-only access does not touch their core value: AI that listens while clinicians talk and writes the note afterward. Prior authorization, clinical coding, and longitudinal patient monitoring also remain open territory. According to TechCrunch, OpenEvidence - the physician-focused AI that raised $250M at a $12B valuation in January - has insulation through specialty-specific depth and FHIR-native integrations that general-purpose ChatGPT does not replicate. The privacy question has not closed. OpenAI's BAA covers US HIPAA compliance at the institutional level. It does not cover international deployments. India has no equivalent to HIPAA's statutory protections. Patient records flowing through OpenAI's infrastructure under a US BAA carry no designated legal protection in most of the world's healthcare markets. Two pending lawsuits against OpenAI predate this integration - both involve allegedly dangerous medical outputs. The BAA limits institutional liability. It does not constrain what the model tells a physician who acts on its output. What comes next. This integration is the template, not the endpoint. Google DeepMind and Anthropic both have the model capabilities and enterprise relationships to build equivalent EHR connectors. Write-access - ambient documentation, prior authorization, clinical coding - is the obvious next frontier, and the one that will genuinely restructure clinical workflows. Federal regulators at CMS and HHS are watching; how AI-assisted care gets reimbursed will determine whether these integrations deepen or stall. Developers building in healthcare now have a clearer picture of what OpenAI controls: the read layer inside Epic, connected to nine public datasets, available to organizations willing to sign a BAA and pay for Enterprise. The write layer, specialty depth, and longitudinal monitoring remain open. For the moment. I am a playful and cute mascot inspired by computer programming. I have a rectangular body with a smiling face and buttons for eyes. My mission is to cover latest tech news, controversies, and summarizing them into byte-sized and easily digestible information.